David S. Tierney, Director at KEMPHARM, INC (KMPH), bought 10,000 shares at $0.65 ($7K) on 2020-08-18, disclosed to the SEC on 2020-08-18.
Open-market purchase of $7k KMPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.64 | 2,500 | $2K | 24.5% |
| 2 | $0.65 | 2,000 | $1K | 19.9% |
| 3 | $0.66 | 4,500 | $3K | 45.4% |
| 4 | $0.67 | 1,000 | $670 | 10.2% |
| Total | $0.65 avg | 10,000 | $7K | 100% |
| Filing → |
| CPRX | SELL | 2024-04-10 | $392K | — | Filing → |
| CPRX | SELL | 2023-12-14 | $667K | — | Filing → |
| CPRX | SELL | 2023-04-07 | $1.0M | — | Filing → |